BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15876154)

  • 21. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI; Moraes L; Bastos AU; Besson P; Alves MT; Delcelo R; Monte O; Longui C; Cury AN; Cerutti JM
    Thyroid; 2017 Feb; 27(2):182-188. PubMed ID: 27849443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RET oncogene expression of papillary thyroid carcinoma in Korea.
    Chung KW; Chang MC; Noh DY; Oh SK; Choe KJ; Youn YK
    Surg Today; 2004; 34(6):485-92. PubMed ID: 15170542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
    Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
    J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
    Basolo F; Giannini R; Monaco C; Melillo RM; Carlomagno F; Pancrazi M; Salvatore G; Chiappetta G; Pacini F; Elisei R; Miccoli P; Pinchera A; Fusco A; Santoro M
    Am J Pathol; 2002 Jan; 160(1):247-54. PubMed ID: 11786418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
    Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
    Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
    Lam KY; Lo CY; Leung PS
    Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
    Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
    Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
    Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
    Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia.
    Chua EL; Wu WM; Tran KT; McCarthy SW; Lauer CS; Dubourdieu D; Packham N; O'Brien CJ; Turtle JR; Dong Q
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2733-9. PubMed ID: 10946873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients.
    Di Cristofaro J; Vasko V; Savchenko V; Cherenko S; Larin A; Ringel MD; Saji M; Marcy M; Henry JF; Carayon P; De Micco C
    Endocr Relat Cancer; 2005 Mar; 12(1):173-83. PubMed ID: 15788648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.
    Nakazawa T; Murata S; Kondo T; Niu D; Mochizuki K; Kawasaki T; Yamane T; Nakamura N; Katoh R
    Virchows Arch; 2009 Jul; 455(1):35-41. PubMed ID: 19495791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
    Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM
    Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncogenic rearrangements of the ret proto-oncogene in thyroid tumors induced after exposure to ionizing radiation.
    Bounacer A; Wicker R; Schlumberger M; Sarasin A; Suárez HG
    Biochimie; 1997 Oct; 79(9-10):619-23. PubMed ID: 9466701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
    Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Inoue T; Tahara I; Kasai K; Hirokawa M; Tran TM; Katoh R
    Cancer Med; 2016 Aug; 5(8):1883-9. PubMed ID: 27264674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
    Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of papillary thyroid carcinoma is facilitated by using an RT-PCR approach on laser-microdissected archival material to detect RET oncogene activation.
    Lahr G; Stich M; Schütze K; Blümel P; Pösl H; Nathrath WB
    Pathobiology; 2000; 68(4-5):218-26. PubMed ID: 11279350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
    Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.